Germany · Pharmaceuticals
Pharmaceuticals
Biotechnology
Healthcare
alytas therapeutics GmbH is a spin-off of the University Hospital Jena, dedicated to developing innovative antibody-based therapy concepts for the treatment of morbid obesity (Adipositas). Obesity is one of the most significant risk factors for health and well-being in the 21st century. The company has expertise and patents related to various antigenic epitopes with proven relevance for the novel therapeutic immunological regulation of excessive amounts of hypertrophic adipocytes.
2019
Founded
Pharmaceuticals
Industry
Germany
Location
613,098,310
Ranking
0 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
